Capital-Restructuring (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr. Lal PathLabs Limited announces bonus issue of equity shares in 1:1 ratio with record date December 19, 2025 and effective listing date … | |||||||||||||||
Dr. Lal PathLabs Limited announces bonus issue of equity shares in 1:1 ratio with record date December 19, 2025 and effective listing date December 23, 2025.
| |||||||||||||||
Modification of debenture trust deed covenants relating to shareholding and management control due to change in capital structure and … | |||||||||||||||
Modification of debenture trust deed covenants relating to shareholding and management control due to change in capital structure and shareholder exit.
| |||||||||||||||
Welcure Drugs & Pharmaceuticals Ltd has allotted 11,23,58,200 bonus equity shares in the ratio of 1:10, effective October 17, 2025, … | |||||||||||||||
Welcure Drugs & Pharmaceuticals Ltd has allotted 11,23,58,200 bonus equity shares in the ratio of 1:10, effective October 17, 2025, following a stock split from Rs. 10 to Re. 1 face value.
| |||||||||||||||
Welcure Drugs & Pharmaceuticals Limited announces bonus issue of 1:10 ratio with deemed allotment date of October 17, 2025 and effective … | |||||||||||||||
Welcure Drugs & Pharmaceuticals Limited announces bonus issue of 1:10 ratio with deemed allotment date of October 17, 2025 and effective listing date of October 20, 2025.
| |||||||||||||||
NSE announces face value split of Rolex Rings Limited equity shares from Rs. 10 to Re. 1, effective October 17, 2025. | |||||||||||||||
NSE announces face value split of Rolex Rings Limited equity shares from Rs. 10 to Re. 1, effective October 17, 2025.
| |||||||||||||||